We're pleased to share today's ASX announcement that ELS received its first large order from its French-based partner, Alrena, in the new Telemedicine vertical.
Alrena was able to place the order after securing its first large-scale investment (2 million Euros) that was reviewed and approved by Project Evaluation Committee of Chamber of Commerce (CCI Val-De-Marne). The investment will be jointly funded by BPIFrance (The Bank of Entrepreneurs of France) as well as by private and other institutional investors. This investment allows Alrena to scale up its sales and operations.
This is the first large order from Alrena since they entered into the exclusive telemedicine deal with Elsight conditional on orders totalling 6 million Euros over 3 years.
Please click here for today's ASX announcement.
Corporate Finance - Executive Director
Gleneagle Securities (Aust) Pty Limited
Level 27, 25 Bligh Street, Sydney NSW 2000
Ph: +612 8277 6683